Rel Capital FY13 results on May 16, 2013

Related to : Bacil Pharma Ltd,Bajaj Finserv Ltd,Reliance Capital Ltd Bacil Pharma Ltd BSE 11 Jun 13 | 12:00 AM 2.96 0 (0%) NSE 01 Jan 70 | 05:30 AM 0.00 0 (0%) Shares of frontline non-banking finance companies (NBFC's) like ...

Nooresh Mirani, AVP Technical of AMSEC Research recommends buying Reliance Capital, Power Finance Corporation, Gujarat State Fertilizers Chemicals, Aditya Birla Nuvo.

In an interview with ET Now, Madhusudan Kela, Chief Investment Strategist, Reliance Capital, shares his views on the rupee and the market. Excerpts: Nikunj Dalmia: Last time when we interacted on this forum, you had three big calls -- gold will ...

Rajesh Agarwal of Eastern Financiers advises buying Mahindra Ugine for a target price of Rs 85 and Panacea Biotec for a target price of Rs 135.

BSE Sensex and Nifty consolidated today after surging more than 2 percent yesterday on hopes of rate cut. Reliance Capital reported consolidated net profit of Rs 265 crore in the fourth quarter. The stock was flat.

Indian markets continued to trade flat towards closing on Wednesday. Oil & gas, realty and capital goods stocks gained. At 2.54 pm, the Sensex was trading up 26.30 points or 0.13% at 19,572.08 with 18 components gaining. Meanwhile, the Nifty was trading ...

The market has gathered momentum in afternoon trade. The Nifty is inching closer to 5850 levels led by capital goods, autos and select heavies. The Sensex is up 119.01 points at 19296.94, and the Nifty is up 36.55 points at 5844.95.

Indian equities remain firm, led by gains in HDFC and Reliance Industries shares. Auto, capital goods, telecom too play a supportive role in today's afternoon trade.

SBI and Reliance Industries, two of the highest tax payers in the financial capital, today showed increase in the first quarter advance tax outgoes. State Bank of India said it paid Rs 1,202 crore in advance tax for the first quarter as against Rs 1,173 crore ...